Injection or Oral GS-441524 for FIP in Cats: Which Is Better?

Both injectable and oral GS-441524 treat Feline Infectious Peritonitis (FIP), and they use the same core antiviral, so neither is simply "weaker." Injectable GS-441524 is the established first choice for serious cases, including ocular and neurological FIP and cats who are not eating or pooping normally, because it delivers a reliable dose straight into the body. Oral options suit stable cats with wet or dry FIP, often once the cat has improved on injections. The best route depends on the form of FIP, your cat's stability, and your veterinarian's assessment.

You are not the first Pawrent in India to face this choice, and your cat's odds are better than they have ever been. Since 2019, more than 100,000 cats have been treated, and the GS-441524 track record is the reason hope is realistic today. Let us walk through how the two routes compare so you can make a calm, informed decision alongside your veterinarian.

A cat resting comfortably at home.

What is GS-441524 and how does it treat FIP?

GS-441524 is the antiviral that stops the FIP virus from copying itself, giving your cat's body the room it needs to recover. It is the hero ingredient in the BasmiFIP FIP antiviral line, and it is the most studied treatment for this disease.

FIP comes in four forms: wet (effusive), dry (non-effusive), ocular, and neurological. Ocular and neurological FIP are two separate forms, not one, and they often need a higher dose because the drug must reach the eyes or the brain and spinal cord.

In the UC Davis clinical trial, GS-441524 reached a 92% success rate in cats treated for FIP. That figure is why so many families now see remission as a genuine, reachable goal rather than a distant wish.

Is injectable or oral GS-441524 better for FIP?

Injectable GS-441524 is generally the stronger, more reliable starting point, especially for ocular FIP, neurological FIP, and any cat who is vomiting, not eating, or not defecating normally. Oral GS-441524 is an excellent option for stable cats with wet or dry FIP, and many families move to oral capsules once the cat is eating well and gaining strength.

The reason injections are preferred at the start is simple. A daily injection delivers a precise, fully absorbed dose, which matters most when a cat is critically ill or when the virus has reached the eyes or nervous system.

Oral capsules shine on comfort and convenience. Once a cat is stable, a daily capsule is far gentler on both the cat and the Pawrent, and it removes the daily stress of an injection.

How do the BasmiFIP GS-441524 options compare?

The BasmiFIP FIP line includes an injectable, an EIDD-1931 oral capsule, and a Dual Antiviral oral capsule that combines GS-441524 with EIDD-1931. Here is how the routes line up.

Option	Best for	Key details
GS-441524 injectable (Basmi FIP Antiviral)	All four FIP forms, including ocular and neurological, and unstable cats	40 mg/ml, 99.4% purity, 8 ml vial. Daily injection, 7 days a week, 84-day protocol
EIDD-1931 oral capsules	Wet and dry FIP only, in stable cats	15 mg per capsule, 60 capsules. Not for ocular or neurological FIP, or cats not eating or defecating normally
Dual Antiviral oral capsules (GS-441524 + EIDD-1931)	Stable cats, usually after about 30 days of injections	1 capsule per day. Not during ocular or neurological symptoms, vomiting, or diarrhea

The injectable is the workhorse of FIP treatment because it covers every form of the disease. The oral options give you a smoother path once your cat has turned the corner.

What are the GS-441524 injection doses for each FIP form?

GS-441524 injectable is dosed by the form of FIP, and ocular and neurological cases need the highest dose because the drug must cross into harder-to-reach tissues. Always confirm the exact dose with your veterinarian, who will weigh your cat and check the diagnosis first.

FIP form	GS-441524 injectable dose
Wet (effusive)	6 mg/kg daily
Dry (non-effusive)	8 mg/kg daily
Ocular	10 mg/kg daily
Neurological	10 mg/kg daily

The standard FIP protocol runs for 84 days, which is 12 weeks of daily treatment. Stopping early is one of the most common reasons for relapse, so finishing the full course matters.

During treatment, your veterinarian will track progress with bloodwork. Understanding what FIP blood test results mean during treatment helps you read the recovery journey with confidence rather than worry.

When should you choose oral GS-441524 over injections?

Oral GS-441524 is a strong choice for stable cats with wet or dry FIP, particularly once they are eating, drinking, and behaving more like themselves. Many families start with injections for about 30 days, then move to the Dual Antiviral oral capsule once the cat is stable.

Here is the general regimen logic your veterinarian may follow:

1. For wet or dry FIP without ocular or neurological signs, some cats may begin on EIDD-1931 oral capsules for 30 days, with the course extended if symptoms persist.

2. If symptoms continue past 60 days on the oral route, the plan typically switches to GS-441524 at 10 mg/kg.

3. For ocular or neurological FIP, or any cat not eating or pooping normally, treatment starts with GS-441524 injections for 30 days, after which the cat may switch to the GS-441524 Dual Antiviral capsule.

The Dual Antiviral oral capsule is not for cats under 1 year with wet FIP, and not during ocular or neurological symptoms, vomiting, or diarrhea. Your veterinarian will time the switch based on how your cat is responding, not on a fixed calendar.

How is oral GS-441524 dosed by weight?

The Dual Antiviral oral capsule is given once daily, and the GS-441524 and EIDD-1931 amounts increase with your cat's weight. This combination is used after about 30 days of injections or once the cat is stable.

Cat weight	Dual Antiviral capsule (once daily)
Under 2.5 kg	GS-441524 25 mg + EIDD-1931 5 mg
2.5 to 5 kg	GS-441524 35 mg + EIDD-1931 8 mg
Over 5 kg	GS-441524 50 mg + EIDD-1931 10 mg

EIDD-1931 is a potent antiviral, roughly 7.3 times more potent than GS-441524 by weight, which is part of why the combination is so useful for stubborn cases. You can read more about this approach in our comprehensive guide to dual antiviral therapy for cat owners in India.

One important safety note: no EIDD-1931 product should be used in pregnant, nursing, or breeding cats, because EIDD-1931 is potentially harmful to developing kittens. For these cats, talk with your veterinarian about an injection-only plan.

Does the combination of injection and oral work better?

Combining GS-441524 with EIDD-1931 can help cats who have not responded fully to a single antiviral, including some drug-resistant cases. In a field study by Li and Cheah (2025), dual antiviral therapy achieved 78.3% remission across 46 cats with FIP, including drug-resistant cases.

This 78.3% dual-antiviral figure is separate from the 92% UC Davis figure for general GS-441524 treatment, and the two should not be combined. Each number describes a different study and a different treatment setting.

Indian veterinary teams are paying close attention to this research. You can explore the thinking behind it in our look at the harder questions Indian vets are asking about FIP treatment, and in the BasmiFIP study on dual antiviral remission in 46 cats.

What about cost and convenience in India?

For most families, injections cost less to begin with and cover every form of FIP, while oral capsules cost a little more but remove the daily stress of injecting an unwell cat. The right balance depends on your cat's form of FIP, your budget, and how your cat tolerates handling.

Many Pawrents find a blended path works best: injections during the critical early phase, then a switch to oral once the cat is stable and gaining weight. This keeps reliability high at the start and comfort high through the long middle of the 84-day journey.

Availability has improved a great deal across Indian cities. If you are searching locally, our guide on where to buy GS-441524 antiviral injections in Bengaluru shows how the supply and consultation process now works.

What should you avoid during GS-441524 treatment?

During FIP treatment, avoid fluoroquinolone antibiotics, spot-on flea medications, lysine, and immune boosters, as these can interfere with recovery. Always tell your veterinarian about every product and supplement your cat is taking.

Supportive nutraceuticals can sit alongside antiviral treatment, but they are not antivirals and do not treat FIP. LiverRx (with SAMe, milk thistle Silybin A+B, Vitamin E, and Vitamin C) and KidneyRx (with Omega-3, L-Carnitine, cranberry extract, and more) are adjunct organ support only, used under veterinary guidance to help the body cope during a demanding treatment.

Think of these as gentle help for the liver and kidneys while the antiviral does the real antiviral work. Your veterinarian can advise whether they fit your cat's recovery journey.

FAQ

Is oral GS-441524 as effective as injections for FIP?

Oral GS-441524 works well for stable cats with wet or dry FIP, while injections are the more reliable choice for ocular FIP, neurological FIP, and cats who are very unwell. Many cats start on injections and move to oral once stable, which gives both reliability and comfort.

Can I use oral capsules for ocular or neurological FIP?

No. EIDD-1931 oral capsules are not recommended for ocular or neurological FIP. These two forms are best treated with GS-441524 injections at 10 mg/kg, because the antiviral must reach the eyes, brain, and spinal cord, and your veterinarian will confirm the plan.

How long is the GS-441524 treatment course?

The standard FIP protocol is 84 days, which is 12 weeks of daily treatment. Finishing the full course is important, because stopping early is a common cause of relapse even when the cat looks fully recovered.

Can pregnant or nursing cats take oral GS-441524 combinations?

No. Any product containing EIDD-1931 should not be used in pregnant, nursing, or breeding cats, because EIDD-1931 can harm developing kittens. Speak with your veterinarian about an injection-based plan for these cats.

What success rates are reported for GS-441524?

The UC Davis clinical trial reported a 92% success rate for general GS-441524 treatment of FIP. In a separate field study, Li and Cheah (2025) reported 78.3% remission with dual antiviral therapy across 46 cats, including drug-resistant cases.

You do not have to figure this out alone, and there is a clear path forward that starts with the right diagnosis. To compare the available treatment options and arrange a free consultation, reach out to the BasmiFIP India team and talk through the plan with them and your own veterinarian. Every cat is different, so let your veterinarian guide the final decision for your cat's recovery journey.